GlassScriptPhysician profile
Catesby Ulversoy
NPI 1407589534
$944.49
in general payments reported to CMS, 2019-2025
20 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $303 · 2023: $225 · 2024: $35.09 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $211.28 | 2022-2023 | |
| Tactile Systems Technology INC | $140.70 | 2025 | Flexitouch Plus, Nimbl |
| Merck Sharp & Dohme LLC | $123.38 | 2022-2023 | Verquvo |
| Biohaven Pharmaceutical Holding Company LTD. | $69.65 | 2022 | |
| Ardelyx, INC. | $48.94 | 2025 | Ibsrela |
| Medtronic, INC. | $35.55 | 2022-2024 | Venaseal |
| Janssen Scientific Affairs, LLC | $29.52 | 2025 | Tremfya |
| Lilly USA, LLC | $29.48 | 2023 | Jardiance |
| Qol Medical, LLC | $28.04 | 2025 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $25.98 | 2025 | Dupixent |
| Madrigal Pharmaceuticals | $25.56 | 2025 | Rezdiffra |
| Genzyme Corporation | $24.23 | 2025 | |
| Novo Nordisk INC | $22.58 | 2022 | |
| Indivior INC. | $20.06 | 2022 | |
| Celltrion USA INC. | $19.84 | 2025 | Vegzelma |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $19.76 | 2025 | Stelara, Tremfya, Simponi |
| Aimmune Therapeutics, INC. | $18.68 | 2025 | Zenpep |
| Nevro Corp. | $17.92 | 2024 | Senza |
| Idorsia Pharmaceuticals US INC | $17.81 | 2023 | Quviviq |
| Exact Sciences Corporation | $15.53 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catesby Ulversoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.